@FierceMedDev: Medical device VC cash plunged 13% in 2012. Report | Follow @FierceMedDev
@DamianFierce: So, is $LIFE looking to sell itself? This PR is ominous. Release | Follow @DamianFierce
> St. Jude Medical ($STJ) won CE mark approval for its Amplatzer Amulet Left Atrial Appendage Occluder, designed to treat non-valvular atrial fibrillation. News
> A new study finds that Medtronic's ($MDT) CoreValve and Edwards Lifesciences' ($EW) Sapien have similar rates of complication and death. Item
> GE Healthcare ($GE) is touting new data showing that its training program is a success in teaching physicians how to read PET scans with its Alzheimer's-related flutemetamol imaging agent. More
> According to a new follow-up study, gastric banding is a safe and effective long-term solution for obese patients. Item
> MIT and Children's Medical Center are suing Shire ($SHPGY), saying the company violated three of their patents with its DermaGraft treatment. Article
> InVitae, led by former Genomic Health ($GHDX) CEO Randy Scott, is gearing up to start development of diagnostic assays that combine many existing tests into one. Story
> Diagnostic smartphone apps that claim to able to distinguish between benign lesions and melanoma produce unreliable, highly variable results, according to a study. Report
Biotech News
@FierceBiotech: NuPathe jumps on FDA's OK for migraine drug. News | Follow @FierceBiotech
@JohnCFierce: VC ends '12 on a high note, outlook ranges from tough to terrific. More | Follow @JohnCFierce
@RyanMFierce: Does anyone know how much total funding (VC, corp., foundation) went into biotech? Still, $800M off in 2012 from '11 on the VC front. Yikes. | Follow @RyanMFierce
> Beer molecule discovery bolsters Seattle biotech upstart. Report
> Pfizer, Novartis win EU nods for new leukemia, eye drugs. Article
> Santhera Pharma slammed with EU denial of orphan drug. Story
Pharma News
@FiercePharma: Not as good for branded pharma, CHMP also OK'd generic versions of Forest's Namenda + Boehringer's Micardis. More | Follow @FiercePharma
@AlisonBFierce: Roche said U.S. regulators will allow it to begin selling the company's reserve stock of adult Tamiflu capsules. News | Follow @AlisonBFierce
@EricPFierce: Costco jumps into pharmacy benefits, bringing a new player to the table for drug companies to think about. Report | Follow @EricPFierce
> Pfizer's Bosulif set for greater sales with EMA approval. Article
> Pfizer sets share price for animal health spinoff. Report
> FTC says pay-to-delay getting worse; GpHA says nonsense. News